Posts by Robert S. Bader, M.D., Dermatologist
HIGH COSTS CITED AS MAJOR REASON PATIENTS DO NOT ADHERE TO THEIR TREATMENTS
Has anybody seen the changes in the cost of medications lately? In case you have not noticed, they have soared completely out of control. For example, a bottle of 100 doxycycline capsules used to cost about $4. Today that same bottle is well over $100. Patients are faced with high copayments for their medications, which…
Read MoreINFECTIONS AFTER A PEDICURE
Patients often ask about the risk of getting infections after a Pedicure. In most cases, they are asking about getting a toenail fungal infection, which is rare in this circumstance. Bacterial infections have occurred after getting a Pedicure, although is uncommon. Those who are immuno-compromised or have diabetes and/or poor circulation are more at risk…
Read MoreI HAVE A SKIN PROBLEM: WHO SHOULD I SEE?
Without question, it is ALWAYS best to see a well-trained, board-certified Dermatologist if one has any skin problems (rashes or growths). Although many PCPs and Urgent care centers can handle COMMON problems (i.e. Shingles, poison ivy and minor burns), what happens when both you and the doctor does not know what the diagnosis is? In many of these cases, patients…
Read MoreHIGH DEDUCTIBLE: CHOOSE YOUR DERMATOLOGIST WISELY!
Nowadays it is common to have a very high deductible. This is a big problem as patients are bearing a significant cost. In this case, it is very important to choose your doctor wisely!!! Let me give you a few examples and some critical information. Contracted Rates–some plans pay doctors very differently. In fact, one…
Read MoreACNE ASSOCIATED WITH INCREASED RISK OF MAJOR DEPRESSION
According to a study published in the British Journal of Dermatology, there was approximately a 5% higher risk of Major Depression in patients diagnosed with Acne. This increased risk lasted approximately 5 years.
Read MoreNEW DRUGS FOR PSORIASIS LOOKING GREAT!
TYK2 inhibitor is being developed by Bristol-Myers Squibb and the early Phase II trial results have been great. Why? Here is the scientific talk: the TYK2 inhibitor has been shown to be 100 times more selective in inhibiting IL-23 , IL-12, and interferon-alpha than JAK 1/3 inhibitors and 3,000 times more selective than JAK 2 inhibitors. What do you…
Read MoreTHERE IS NO REASON TO RE-EXCISE A MODERATELY-ATYPICAL NEVUS
To those who are patients and those who follow my posts, you know that I am adamant that there has been an over-treatment of these atypical nevi for decades. In short, the data just does not support the removal of these lesions–PERIOD! Another study was just completed at Emory University (Atlanta) and Atlanta Veterans Administration Medical…
Read More“BETTER THAN BOTOX?”
Revance Therapeutics Inc. said that an experimental drug RT002 [injectable daxibotulinumtoxinA] can smooth wrinkles for longer than Allergan’s Botox, according to the results of late-stage studies. We will have to wait for the published data to see, but at least early reports look promising.
Read MoreBEDBUGS
This is becoming a big problem, but one can solve this most often without additional help. Here are a couple of references: https://www.aad.org/public/diseases/itchy-skin/bedbugs https://www.jenreviews.com/bed-bugs/
Read MoreBOTOX COSMETIC IS NOW FDA APPROVED FOR THE TREATMENT OF THE FOREHEAD
Botox and Dysport have been used to treat the forehead for nearly 2 decades as an “off label indication”. This has no impact on the treatment of the forehead furrows, but it does have the FDA’s stamp of approval. To celebrate this we are offering treatment of the forehead for $199. This does not include the…
Read More